<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-08T07:48:51+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>全面落实MAH制度，还有哪些挑战？ | 年度</title>
    <updated>2021-01-07T23:26:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/pgsjX1iudJT9HO3pLo6clQ</id>
    <link href="https://mp.weixin.qq.com/s/pgsjX1iudJT9HO3pLo6clQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第39届摩根大通医疗健康年会：中国企业速览 | 大话JPM</title>
    <updated>2021-01-07T23:26:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/FqKalaG7gjhm40rzQXCZYg</id>
    <link href="https://mp.weixin.qq.com/s/FqKalaG7gjhm40rzQXCZYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科越医药宣布获得5350万美元的B+轮1期融资 | 新闻稿</title>
    <updated>2021-01-07T23:26:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-07:/s/qB0MePkqyPa8BcUZ5SkV5g</id>
    <link href="https://mp.weixin.qq.com/s/qB0MePkqyPa8BcUZ5SkV5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国创新回报三个关键词 | 年度</title>
    <updated>2021-01-06T23:38:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/GbY33mWqWUnZq-gSfYJ7YQ</id>
    <link href="https://mp.weixin.qq.com/s/GbY33mWqWUnZq-gSfYJ7YQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临研通“临床研究型医院”落户天津武清 | 新闻稿</title>
    <updated>2021-01-06T23:38:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/VkKAUMC77K7VFhxXbZ8e2g</id>
    <link href="https://mp.weixin.qq.com/s/VkKAUMC77K7VFhxXbZ8e2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>乘风破浪 逆势生长 中国医药创新投资论坛精彩抢先看 | 会讯</title>
    <updated>2021-01-06T23:38:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/d5LiFJCqNaa-dpcsFaLZWw</id>
    <link href="https://mp.weixin.qq.com/s/d5LiFJCqNaa-dpcsFaLZWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复盘泽布替尼研发历程 | 年度</title>
    <updated>2021-01-05T22:36:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/YcS9qE3P0PYtNif1EImTeg</id>
    <link href="https://mp.weixin.qq.com/s/YcS9qE3P0PYtNif1EImTeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年中国获批新药的高光时刻 | 年度</title>
    <updated>2021-01-04T22:46:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/8xUEtlxFZFGnyOSaMmVUoQ</id>
    <link href="https://mp.weixin.qq.com/s/8xUEtlxFZFGnyOSaMmVUoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>时序更替的2020，请记住中国生物医药！| 年度</title>
    <updated>2021-01-03T23:18:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/PaeV1OdJ3GC9WgsgQ7iXcQ</id>
    <link href="https://mp.weixin.qq.com/s/PaeV1OdJ3GC9WgsgQ7iXcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药在韩国提交ATG-010（Selinexor）新药上市申请，治疗复发难治性多发性骨髓瘤及弥漫性大B细胞淋巴瘤 |新闻稿</title>
    <updated>2021-01-03T23:18:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/nmZ28ljq9zUg7TueWQfURg</id>
    <link href="https://mp.weixin.qq.com/s/nmZ28ljq9zUg7TueWQfURg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>警惕静脉注射剂中的苯甲醇引发的不良反应 | 正见</title>
    <updated>2021-01-02T22:55:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/kjP7io2knxXegNc8Rh4Thw</id>
    <link href="https://mp.weixin.qq.com/s/kjP7io2knxXegNc8Rh4Thw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“超光速行动”——科学的胜利 |老梁说药</title>
    <updated>2021-01-01T20:53:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/iGXn4JVPDUTttQ61aJLHNQ</id>
    <link href="https://mp.weixin.qq.com/s/iGXn4JVPDUTttQ61aJLHNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创世纪 | 年度</title>
    <updated>2020-12-31T19:11:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/lkJCIJsXmwmdrOnBwoHucw</id>
    <link href="https://mp.weixin.qq.com/s/lkJCIJsXmwmdrOnBwoHucw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物警戒制度上升到战略层面 | DRR专题· 新理念</title>
    <updated>2020-12-30T18:21:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/bCKLxueB_XUR5JTx6YqEFA</id>
    <link href="https://mp.weixin.qq.com/s/bCKLxueB_XUR5JTx6YqEFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>优先审评审批和特别审批：聚焦临床价值 | DRR·注册程序</title>
    <updated>2020-12-29T21:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/F2ptxxA6oS8otlxF3mnaow</id>
    <link href="https://mp.weixin.qq.com/s/F2ptxxA6oS8otlxF3mnaow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20201230 本周职位精选：谷孚招聘科技项目主管 | 招聘</title>
    <updated>2020-12-29T21:18:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/-AUxdNYBeFCVa5OlEuDVnQ</id>
    <link href="https://mp.weixin.qq.com/s/-AUxdNYBeFCVa5OlEuDVnQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>